CAMRELIZUMAB

Search structure
Synonyms:
Status: Phase 3
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 73096E137E

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Programmed cell death protein 1 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Squamous Cell Carcinoma of Head and Neck 3 D000077195 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Triple Negative Breast Neoplasms 3 D064726 ClinicalTrials
Nasopharyngeal Carcinoma 3 D000077274 ClinicalTrials
Nasopharyngeal Neoplasms 3 D009303 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Small Cell Lung Carcinoma 3 D055752 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Carcinoma, Hepatocellular 3 D006528 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Carcinoma, Squamous Cell 3 D002294 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Hodgkin Disease 3 D006689 ClinicalTrials
Esophageal Neoplasms 3 D004938 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Colonic Neoplasms 2 D003110 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Meningeal Carcinomatosis 2 D055756 ClinicalTrials
Carcinoma, Neuroendocrine 2 D018278 ClinicalTrials
Gestational Trophoblastic Disease 2 D031901 ClinicalTrials
Paranasal Sinus Neoplasms 2 D010255 ClinicalTrials
Adenocarcinoma of Lung 2 D000077192 ClinicalTrials
Endometrial Neoplasms 2 D016889 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Leukemia, Myeloid, Acute 2 D015470 ClinicalTrials
Osteosarcoma 2 D012516 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Hypopharyngeal Neoplasms 2 D007012 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Rectal Neoplasms 2 D012004 ClinicalTrials
Adrenal Cortex Neoplasms 2 D000306 ClinicalTrials
Cholangiocarcinoma 2 D018281 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Granuloma, Lethal Midline 2 D006103 ClinicalTrials
Lung Neoplasms 2 D008175 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Thyroid Neoplasms 2 D013964 ClinicalTrials
Uterine Cervical Neoplasms 2 D002583 ClinicalTrials
Biliary Tract Neoplasms 2 D001661 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Carcinoma, Renal Cell 2 D002292 ClinicalTrials
Endometrial Neoplasms 2 D016889 ClinicalTrials
Adenocarcinoma 2 D000230 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Urinary Bladder Neoplasms 2 D001749 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Lymphoma, T-Cell, Peripheral 1 D016411 ClinicalTrials
Mouth Neoplasms 1 D009062 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials
Pleural Effusion 1 D010996 ClinicalTrials
Carcinoma, Pancreatic Ductal 1 D021441 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297715
FDA SRS 73096E137E
CONTENTS